Aeolus reports positive results from Lou Gehrig's drug study
12th Sep 2005, 13:51 GMT
Aeolus Pharmaceuticals has announced positive results from an early phase clinical trial into its investigational drug AEOL 10150 in patients with amyotrophic lateral sclerosis, otherwise known as ALS or Lou Gehrig's disease.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol